186 related articles for article (PubMed ID: 19663117)
1. Alpha-melanocyte stimulating hormone analogues: the perils and the promise.
Mazza JM; Zippin JH
J Drugs Dermatol; 2009 Aug; 8(8):772-6. PubMed ID: 19663117
[No Abstract] [Full Text] [Related]
2. A review and update on melanocyte stimulating hormone therapy: afamelanotide.
Fabrikant J; Touloei K; Brown SM
J Drugs Dermatol; 2013 Jul; 12(7):775-9. PubMed ID: 23884489
[TBL] [Abstract][Full Text] [Related]
3. An alpha-melanocyte-stimulating hormone analogue in erythropoietic protoporphyria.
Harms J; Lautenschlager S; Minder CE; Minder EI
N Engl J Med; 2009 Jan; 360(3):306-7. PubMed ID: 19144952
[No Abstract] [Full Text] [Related]
4. Afamelanotide, an agonistic analog of α-melanocyte-stimulating hormone, in dermal phototoxicity of erythropoietic protoporphyria.
Minder EI
Expert Opin Investig Drugs; 2010 Dec; 19(12):1591-602. PubMed ID: 21073357
[TBL] [Abstract][Full Text] [Related]
5. [Alpha-melanocyte-stimulating hormone. From bench to bedside].
Böhm M; Luger TA
Hautarzt; 2010 Jun; 61(6):497-504. PubMed ID: 20512306
[TBL] [Abstract][Full Text] [Related]
6. Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria.
Minder EI; Schneider-Yin X
Expert Rev Clin Pharmacol; 2015 Jan; 8(1):43-53. PubMed ID: 25470471
[TBL] [Abstract][Full Text] [Related]
7. Mitigating photosensitivity of erythropoietic protoporphyria patients by an agonistic analog of alpha-melanocyte stimulating hormone.
Harms JH; Lautenschlager S; Minder CE; Minder EI
Photochem Photobiol; 2009; 85(6):1434-9. PubMed ID: 19656325
[TBL] [Abstract][Full Text] [Related]
8. Melanotropic peptides: more than just 'Barbie drugs' and 'sun-tan jabs'?
Langan EA; Nie Z; Rhodes LE
Br J Dermatol; 2010 Sep; 163(3):451-5. PubMed ID: 20545686
[TBL] [Abstract][Full Text] [Related]
9. An α-MSH analog in erythropoietic protoporphyria.
Luger TA; Böhm M
J Invest Dermatol; 2015 Apr; 135(4):929-931. PubMed ID: 25785940
[No Abstract] [Full Text] [Related]
10. Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH.
Haylett AK; Nie Z; Brownrigg M; Taylor R; Rhodes LE
Br J Dermatol; 2011 Feb; 164(2):407-14. PubMed ID: 20969564
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders.
Minder EI; Barman-Aksoezen J; Schneider-Yin X
Clin Pharmacokinet; 2017 Aug; 56(8):815-823. PubMed ID: 28063031
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet protection without ultraviolet exposure?
Dawson BV
N Z Med J; 1993 Oct; 106(966):445-7. PubMed ID: 8233174
[No Abstract] [Full Text] [Related]
13. Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria.
Wensink D; Wagenmakers MAEM; Langendonk JG
Expert Rev Clin Pharmacol; 2021 Feb; 14(2):151-160. PubMed ID: 33507118
[No Abstract] [Full Text] [Related]
14. Afamelanotide: A Review in Erythropoietic Protoporphyria.
Kim ES; Garnock-Jones KP
Am J Clin Dermatol; 2016 Apr; 17(2):179-85. PubMed ID: 26979527
[TBL] [Abstract][Full Text] [Related]
15. Pseudoleucoderma after injections of afamelanotide in a patient with atopic dermatitis.
von Bartenwerffer W; Siebenhaar G; Hunzelmann N
Acta Derm Venereol; 2011 Sep; 91(5):578-9. PubMed ID: 21597671
[No Abstract] [Full Text] [Related]
16. Patients with porphyria bask in sunlight of FDA approval.
Ratner M
Nat Biotechnol; 2019 Dec; 37(12):1390-1391. PubMed ID: 31796929
[No Abstract] [Full Text] [Related]
17. Afamelanotide for Erythropoietic Protoporphyria.
Langendonk JG; Balwani M; Anderson KE; Bonkovsky HL; Anstey AV; Bissell DM; Bloomer J; Edwards C; Neumann NJ; Parker C; Phillips JD; Lim HW; Hamzavi I; Deybach JC; Kauppinen R; Rhodes LE; Frank J; Murphy GM; Karstens FPJ; Sijbrands EJG; de Rooij FWM; Lebwohl M; Naik H; Goding CR; Wilson JHP; Desnick RJ
N Engl J Med; 2015 Jul; 373(1):48-59. PubMed ID: 26132941
[TBL] [Abstract][Full Text] [Related]
18. Afamelanotide: An Orphan Drug with Potential for Broad Dermatologic Applications.
Wu J; Cotliar R
J Drugs Dermatol; 2021 Mar; 20(3):290-294. PubMed ID: 33683075
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues.
Lim YJ; Lee EH; Kang TH; Ha SK; Oh MS; Kim SM; Yoon TJ; Kang C; Park JH; Kim SY
Arch Pharm Res; 2009 Mar; 32(3):367-73. PubMed ID: 19387580
[TBL] [Abstract][Full Text] [Related]
20. Melanotropic peptides for therapeutic and cosmetic tanning of the skin.
Hadley ME; Sharma SD; Hruby VJ; Levine N; Dorr RT
Ann N Y Acad Sci; 1993 May; 680():424-39. PubMed ID: 8390162
[No Abstract] [Full Text] [Related]
[Next] [New Search]